202 related articles for article (PubMed ID: 21964481)
1. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: a meta-analytic investigation.
Euser AS; Arends LR; Evans BE; Greaves-Lord K; Huizink AC; Franken IH
Neurosci Biobehav Rev; 2012 Jan; 36(1):572-603. PubMed ID: 21964481
[TBL] [Abstract][Full Text] [Related]
2. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review.
Singh SM; Basu D
Addict Biol; 2009 Jul; 14(3):298-309. PubMed ID: 18811679
[TBL] [Abstract][Full Text] [Related]
3. Direct and mediated associations between P300 amplitude in childhood and substance use disorders outcome in young adulthood.
Habeych ME; Charles PJ; Sclabassi RJ; Kirisci L; Tarter RE
Biol Psychiatry; 2005 Jan; 57(1):76-82. PubMed ID: 15607303
[TBL] [Abstract][Full Text] [Related]
4. Association among parental substance use disorder, p300 amplitude, and neurobehavioral disinhibition in preteen boys at high risk for substance use disorder.
Habeych ME; Sclabassi RJ; Charles PJ; Kirisci L; Tarter RE
Psychol Addict Behav; 2005 Jun; 19(2):123-30. PubMed ID: 16011382
[TBL] [Abstract][Full Text] [Related]
5. Using the brain P300 response to identify novel phenotypes reflecting genetic vulnerability for adolescent substance misuse.
Yoon HH; Iacono WG; Malone SM; McGue M
Addict Behav; 2006 Jun; 31(6):1067-87. PubMed ID: 16644137
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological indices of biased cognitive processing of substance-related cues: a meta-analysis.
Littel M; Euser AS; Munafò MR; Franken IH
Neurosci Biobehav Rev; 2012 Sep; 36(8):1803-16. PubMed ID: 22613258
[TBL] [Abstract][Full Text] [Related]
7. Event-related potentials in substance use disorders: a narrative review based on articles from 1984 to 2012.
Campanella S; Pogarell O; Boutros N
Clin EEG Neurosci; 2014 Apr; 45(2):67-76. PubMed ID: 24104954
[TBL] [Abstract][Full Text] [Related]
8. P300 development during adolescence: effects of DRD2 genotype.
Berman SM; Noble EP; Antolin T; Sheen C; Conner BT; Ritchie T
Clin Neurophysiol; 2006 Mar; 117(3):649-59. PubMed ID: 16426891
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiology and schizophrenic vulnerability: the P300 component as endophenotype candidate?].
Cermolacce M; Micoulaud JA; Naudin J; Vion-Dury J
Encephale; 2011 Oct; 37(5):353-60. PubMed ID: 22032278
[TBL] [Abstract][Full Text] [Related]
10. Effects of borderline personality disorder features and a family history of alcohol or drug dependence on P300 in adolescents.
Houston RJ; Bauer LO; Hesselbrock VM
Int J Psychophysiol; 2004 Jun; 53(1):57-70. PubMed ID: 15172136
[TBL] [Abstract][Full Text] [Related]
11. Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring.
Euser AS; Evans BE; Greaves-Lord K; Huizink AC; Franken IH
Addict Biol; 2013 Nov; 18(6):970-84. PubMed ID: 23145495
[TBL] [Abstract][Full Text] [Related]
12. Substance dependence and externalizing psychopathology in adolescent boys with small, average, or large P300 event-related potential amplitude.
Carlson SR; Katsanis J; Iacono WG; Mertz AK
Psychophysiology; 1999 Sep; 36(5):583-90. PubMed ID: 10442026
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial determinants of target and novelty-evoked P300 amplitudes in children of addicted parents.
Euser AS; Evans BE; Greaves-Lord K; van de Wetering BJ; Huizink AC; Franken IH
PLoS One; 2013; 8(11):e80087. PubMed ID: 24244616
[TBL] [Abstract][Full Text] [Related]
14. P300 amplitude, externalizing psychopathology, and earlier- versus later-onset substance-use disorder.
Carlson SR; McLarnon ME; Iacono WG
J Abnorm Psychol; 2007 Aug; 116(3):565-77. PubMed ID: 17696712
[TBL] [Abstract][Full Text] [Related]
15. D2 dopamine receptor (DRD2) gene, P300, and personality in children of alcoholics.
Antolin T; Berman SM; Conner BT; Ozkaragoz TZ; Sheen CL; Ritchie TL; Noble EP
Psychiatry Res; 2009 Apr; 166(2-3):91-101. PubMed ID: 19278736
[TBL] [Abstract][Full Text] [Related]
16. The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies.
Bestelmeyer PE; Phillips LH; Crombie C; Benson P; St Clair D
Psychiatry Res; 2009 Oct; 169(3):212-9. PubMed ID: 19748132
[TBL] [Abstract][Full Text] [Related]
17. P300 and genetic risk for schizophrenia.
Winterer G; Egan MF; Raedler T; Sanchez C; Jones DW; Coppola R; Weinberger DR
Arch Gen Psychiatry; 2003 Nov; 60(11):1158-67. PubMed ID: 14609891
[TBL] [Abstract][Full Text] [Related]
18. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives.
Yeap S; Kelly SP; Sehatpour P; Magno E; Javitt DC; Garavan H; Thakore JH; Foxe JJ
Arch Gen Psychiatry; 2006 Nov; 63(11):1180-8. PubMed ID: 17088498
[TBL] [Abstract][Full Text] [Related]
19. Alcohol use disorders and anxiety disorders: relation to the P300 event-related potential.
Enoch MA; White KV; Harris CR; Rohrbaugh JW; Goldman D
Alcohol Clin Exp Res; 2001 Sep; 25(9):1293-300. PubMed ID: 11584148
[TBL] [Abstract][Full Text] [Related]
20. The P300 component in patients with Alzheimer's disease and their biological children.
Ally BA; Jones GE; Cole JA; Budson AE
Biol Psychol; 2006 May; 72(2):180-7. PubMed ID: 16337071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
